Adherence of Stalevo, Entacapone and Levodopa

NCT00245700 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2008-05-23

No results posted yet for this study

Summary

To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient.

To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.

Conditions

Sponsors & Collaborators

  • South Glasgow University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Donald G Grosset, MBChB, MD

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2006-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245700 on ClinicalTrials.gov